Rumiko Shimazawa

Summary

Affiliation: Nagasaki University
Country: Japan

Publications

  1. doi request reprint Japanese regulatory system for approval of off-label drug use: evaluation of safety and effectiveness in literature-based applications
    Rumiko Shimazawa
    Graduate School of Biomedical Sciences, Nagasaki University, Japan
    Clin Ther 34:2104-16. 2012
  2. doi request reprint The vaccine gap between Japan and the UK
    Rumiko Shimazawa
    Graduate School of Biomedical Sciences and the Global COE Programme, Nagasaki University, Japan
    Health Policy 107:312-7. 2012
  3. ncbi request reprint Delays in neurological drug development in Japan
    Rumiko Shimazawa
    Graduate School of Biomedical Sciences, Nagasaki University, Japan
    Intern Med 50:1565-8. 2011
  4. doi request reprint Safety information in drug labeling: a comparison of the USA, the UK, and Japan
    Rumiko Shimazawa
    Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan
    Pharmacoepidemiol Drug Saf 22:306-18. 2013

Detail Information

Publications4

  1. doi request reprint Japanese regulatory system for approval of off-label drug use: evaluation of safety and effectiveness in literature-based applications
    Rumiko Shimazawa
    Graduate School of Biomedical Sciences, Nagasaki University, Japan
    Clin Ther 34:2104-16. 2012
    ..This approval scheme involved application evaluation using literature-based evidence; however, the type of indications and the kind of evidence used in practical applications remain to be clarified...
  2. doi request reprint The vaccine gap between Japan and the UK
    Rumiko Shimazawa
    Graduate School of Biomedical Sciences and the Global COE Programme, Nagasaki University, Japan
    Health Policy 107:312-7. 2012
    ..To study and compare the Japanese vaccine policy with the policy in the UK and to discuss factors that may explain the gap in vaccine availability between the two countries...
  3. ncbi request reprint Delays in neurological drug development in Japan
    Rumiko Shimazawa
    Graduate School of Biomedical Sciences, Nagasaki University, Japan
    Intern Med 50:1565-8. 2011
    ..The objective of this study was to analyze the factors contributing to the delay in the launching of neurological drugs in Japan...
  4. doi request reprint Safety information in drug labeling: a comparison of the USA, the UK, and Japan
    Rumiko Shimazawa
    Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan
    Pharmacoepidemiol Drug Saf 22:306-18. 2013
    ..Despite globalization of drug approvals, there is a disparity in drug safety regulations among the USA, Europe, and Japan. We sought to determine differences in safety information on drug labels among the three regions...